» Authors » Michele Luchetti

Michele Luchetti

Explore the profile of Michele Luchetti including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 434
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Luchetti M
Front Psychol . 2024 Jun; 15:1354392. PMID: 38840738
The validity of psychological measurement is crucially connected to a peculiar form of epistemic circularity. This circularity can be a threat when there are no independent ways to assess whether...
2.
Luchetti M
Stud Hist Philos Sci . 2020 Nov; 84:119-131. PMID: 33218458
In this paper, I argue for a distinction between two scales of coordination in scientific inquiry, through which I reassess Georg Simon Ohm's work on conductivity and resistance. Firstly, I...
3.
Ramadori G, Ioris R, Villanyi Z, Firnkes R, Panasenko O, Allen G, et al.
Cell Rep . 2020 Mar; 30(11):3851-3863.e6. PMID: 32187554
Cancer therapy is limited, in part, by lack of specificity. Thus, identifying molecules that are selectively expressed by, and relevant for, cancer cells is of paramount medical importance. Here, we...
4.
Ramadori G, Konstantinidou G, Venkateswaran N, Biscotti T, Morlock L, Galie M, et al.
Cell Metab . 2014 Dec; 21(1):117-25. PMID: 25533479
Dietary effects on tumor biology can be exploited to unravel cancer vulnerabilities. Here, we present surprising evidence for anti-proliferative action of high-calorie-diet (HCD) feeding on KRAS-driven lung tumors. Tumors of...
5.
Donati A, Damiani E, Luchetti M, Domizi R, Scorcella C, Carsetti A, et al.
Crit Care . 2014 Feb; 18(1):R33. PMID: 24528648
Introduction: Microvascular alterations impair tissue oxygenation during sepsis. A red blood cell (RBC) transfusion increases oxygen (O2) delivery but rarely improves tissue O2 uptake in patients with sepsis. Possible causes...
6.
Gabrielli A, Svegliati S, Moroncini G, Luchetti M, Tonnini C, Avvedimento E
Autoimmun Rev . 2007 Nov; 7(2):121-6. PMID: 18035321
Systemic sclerosis (scleroderma) is a complex disease characterized by excessive deposition of collagen and abnormalities of blood vessels. In addition, activation of the immune system is a central feature of...
7.
Svegliati S, Olivieri A, Campelli N, Luchetti M, Poloni A, Trappolini S, et al.
Blood . 2007 Mar; 110(1):237-41. PMID: 17363728
Extensive chronic graft-versus-host disease (ecGVHD) is characterized by fibrosis similar to that of patients with systemic sclerosis (scleroderma). Since stimulatory autoantibodies against the platelet-derived growth factor (PDGF) receptor (PDGFR) have...
8.
Svegliati Baroni S, Santillo M, Bevilacqua F, Luchetti M, Spadoni T, Mancini M, et al.
N Engl J Med . 2006 Jun; 354(25):2667-76. PMID: 16790699
Background: Systemic sclerosis (scleroderma) is characterized by immunologic abnormalities, injury of endothelial cells, and tissue fibrosis. Abnormal oxidative stress has been documented in scleroderma and linked to fibroblast activation. Since...
9.
Svegliati S, Cancello R, Sambo P, Luchetti M, Paroncini P, Orlandini G, et al.
J Biol Chem . 2005 Aug; 280(43):36474-82. PMID: 16081426
The levels of Ras proteins in human primary fibroblasts are regulated by PDGF (platelet-derived growth factor). PDGF induced post-transcriptionally Ha-Ras by stimulating reactive oxygen species (ROS) and ERK1/2. Activation of...